Clin Exp Pediatr.
2024 Feb;67(2):80-89. 10.3345/cep.2022.01452.
Community-acquired pneumonia in children: updated perspectives on its etiology, diagnosis, and treatment
- Affiliations
-
- 1Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2551501
- DOI: http://doi.org/10.3345/cep.2022.01452
Abstract
- Pneumonia is a common pediatric infectious disease that is familiar to pediatricians and a major cause of hospitalization worldwide. Recent well-designed epidemiologic studies in developed countries indicated that respiratory viruses are detected in 30%–70%, atypical bacteria in 7%–17%, and pyogenic bacteria in 2%–8% of children hospitalized with community-acquired pneumonia (CAP). The etiological distribution of CAP varies widely by child age and the epidemiological season of the respiratory pathogen. Moreover, diagnostic tests, particularly for the detection of Streptococcus pneumoniae and Mycoplasma pneumoniae, the 2 major bacterial pathogens involved in pediatric CAP, have several limitations. Therefore, management and empirical antimicrobial therapy for children with CAP should be applied in a stepwise manner based on recent epidemiological, etiological, and microbiological evidence.
